KRYSTAL BIOTECH, INC. (KRYS)
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
A2Z Cust2Mate Solutions to Host First Quarter 2026 Financial Results Conference Call on Friday, May 15, 2026
OTC Markets Group Appoints JP Chan to Lead Asia-Pacific Growth in Hong Kong
Legence Sets First Quarter 2026 Earnings Release Date and Webcast Schedule
Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology"
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026
Phillips 66 to Host Annual Meeting of Shareholders
Middleby Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Middleby Food Processing
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement
Helix Energy Solutions Sells Shallow Water Abandonment Business to the Chouest Group